GHB Drug in Canada: Complete Guide to Legal Status, Effects, Risks & Treatment (2026)
The GHB drug in Canada is one of the most legally restricted and medically dangerous substances in the country. Gamma-hydroxybutyrate (GHB) is classified as a Schedule I controlled substance under the Controlled Drugs and Substances Act (CDSA), placing it in the same legal tier as heroin, cocaine, and fentanyl. Whether you are researching GHB for harm reduction, legal, medical, or academic purposes, this guide covers everything Canadians need to know about the GHB drug — from what it is and how it works to its severe legal consequences and the treatment options available across Canada.
What Is the GHB Drug?
Gamma-Hydroxybutyrate: A Primer
GHB — formally known as gamma-hydroxybutyric acid — is a naturally occurring compound found in trace amounts in the human brain, where it functions as both a metabolite of the inhibitory neurotransmitter GABA and a neuromodulator in its own right. As a recreational drug, GHB is synthesized illicitly and is typically distributed as a clear, odourless, slightly salty liquid — though it also appears in powder and capsule form on the Canadian drug market.
GHB acts primarily on two receptor systems in the central nervous system:
- GABA-B receptors — producing sedation, muscle relaxation, and CNS depression
- GHB-specific receptors — producing euphoria, increased sociability, and mild hallucinogenic effects at low doses
This dual mechanism is what makes GHB simultaneously appealing to recreational users and extraordinarily dangerous — small changes in dose can shift effects from pleasant relaxation to complete unconsciousness or death, with very little warning.
GHB Street Names in Canada
GHB circulates under numerous street names across Canadian cities, including:
- G or Liquid G
- Fantasy
- Grievous Bodily Harm (GBH)
- Liquid Ecstasy (despite no chemical relation to MDMA)
- Cherry Meth
- Scoop or Easy Lay
- Soap or Georgia Home Boy
- Blue Nitro or Midnight Blue (branded GBL products that convert to GHB)
- Sodium Oxybate (pharmaceutical name for the medical form)
Understanding these street names is important for parents, educators, healthcare providers, and law enforcement across Canada who may encounter GHB in community settings.
GHB Drug Legal Status in Canada
Schedule I Under the CDSA
The GHB drug has been a Schedule I controlled substance in Canada since November 6, 2012, upgraded from its previous Schedule III classification. This reclassification was driven by GHB’s increasing role in drug-facilitated sexual assault (DFSA), its documented addiction and overdose risks, and the need to align Canadian law with international drug control standards.
As a Schedule I drug, GHB in Canada is subject to the most severe criminal penalties available under federal drug law:
- Possession: Up to 7 years imprisonment (indictable)
- Trafficking: Up to life imprisonment
- Importation/Exportation: Mandatory minimum 1–2 years, maximum life imprisonment
- Production: Indictable offence with significant imprisonment terms
There is no minimum quantity threshold for a possession charge, no provincial decriminalization, and no recreational exemption anywhere in Canada. GHB laws apply uniformly from British Columbia to Newfoundland.
GHB Precursor Chemicals
GHB’s legal controls in Canada extend to its chemical precursors. Both GBL (gamma-butyrolactone) and 1,4-butanediol (1,4-BD) — industrial chemicals that metabolize directly into GHB once ingested — are classified as Schedule VI, Class A Precursors under the CDSA. Importing or using these chemicals with intent to produce or consume GHB is prosecuted as a Schedule I drug offence — not a lesser regulatory violation.
How GHB Affects the Body
Short-Term Effects
GHB’s effects are highly dose-dependent, and the margin between a recreational dose and an incapacitating or lethal one is dangerously narrow. At typical recreational doses, GHB produces:
- Euphoria and enhanced sociability
- Reduced inhibition and increased libido
- Mild sedation and physical relaxation
- Enhanced sensory perception
- Feelings of emotional warmth and empathy
Dangerous and Overdose-Level Effects
As the dose increases — or when GHB is combined with alcohol or other CNS depressants — effects shift rapidly to:
- Severe sedation and disorientation
- Nausea and vomiting (particularly dangerous if unconscious)
- Loss of coordination and inability to stand or speak
- Sudden unconsciousness — known in Canadian drug culture as “going under” or a “G sleep”
- Respiratory depression — slow, shallow, or stopped breathing
- Seizures
- Coma and death
The combination of GHB and alcohol is particularly lethal in Canada — alcohol dramatically amplifies GHB’s CNS depressant effects, making the already-narrow safe dose window essentially impossible to navigate reliably.
GHB and Drug-Facilitated Sexual Assault in Canada
A Primary DFSA Drug
The GHB drug is one of the most commonly identified substances in drug-facilitated sexual assault (DFSA) cases across Canada, alongside Rohypnol and Ketamine. Its properties make it uniquely dangerous in assault contexts:
- Colourless and nearly odourless — dissolves invisibly into beverages
- Rapid onset — effects begin within 15–30 minutes of ingestion
- Potent amnesiac effects — victims frequently recall little or nothing
- Short detection window — GHB metabolizes quickly, making forensic evidence time-sensitive
- Lethal synergy with alcohol — drinks spiked with GHB at social events dramatically increase overdose risk
In Canada, administering GHB to another person without consent — for any purpose — triggers prosecution under both the CDSA and the Criminal Code of Canada, resulting in compounded criminal charges and substantially longer sentences.
GHB Drug Use Patterns in Canada
Who Uses GHB in Canada?
GHB use in Canada is concentrated in specific social and demographic contexts:
- Urban nightlife environments — clubs, raves, and entertainment venues in Toronto, Vancouver, Montreal, and Calgary
- Chemsex communities — GHB is one of three primary drugs (alongside methamphetamine and mephedrone) used in chemsex, particularly within some LGBTQ+ urban communities
- Fitness and bodybuilding subcultures — historically, GHB was used for its purported growth hormone-stimulating and muscle-recovery properties, though these claims are not scientifically validated
- University and college campuses — though less prevalent than alcohol or cannabis, GHB appears in campus drug scenes particularly in major Ontario and BC universities
The clandestine and liquid nature of GHB makes reliable national usage statistics difficult to compile, but Canadian harm reduction organizations consistently identify GHB as an underreported drug with a higher addiction and hospitalization rate relative to its perceived prevalence.
GHB Drug Addiction and Dependence in Canada
Rapid Physical Dependence
GHB addiction develops significantly faster than most recreational drugs. Regular users — particularly those dosing multiple times per day — can develop physical dependence within weeks. The mechanism is straightforward: chronic GHB use causes the brain to downregulate its own GABA activity, creating a state of neurological dependence where GHB is needed simply to maintain normal brain function.
Signs of GHB addiction in Canadian users include:
- Dosing every 2–4 hours, including waking through the night to re-dose
- Escalating tolerance requiring larger doses for the same effect
- Inability to reduce or stop use despite wanting to
- Continued use despite legal, health, relationship, and financial consequences
- Intense anxiety and physical symptoms between doses
GHB Withdrawal: Medically Dangerous
GHB withdrawal in Canada is a medical emergency. Unlike most drug withdrawals, GHB withdrawal can progress from mild anxiety to life-threatening seizures and psychosis within hours of the last dose. Withdrawal symptoms include:
- Onset (1–6 hours after last dose): Anxiety, tremors, sweating, insomnia, rapid heart rate
- Peak severity (24–72 hours): Hallucinations, delirium, severe psychosis, grand mal seizures, cardiovascular instability
- Acute phase duration: 5–15 days under medical supervision
Home detox from GHB is strongly contraindicated by Canadian medical professionals. Hospital-level or residential detox with 24/7 medical supervision is the minimum safe standard for GHB withdrawal management.
Medical Use of GHB in Canada
Sodium Oxybate (Xyrem)
The GHB drug has exactly one legally recognized medical application in Canada. Sodium oxybate — the pharmaceutical-grade formulation of GHB — is available under the brand name Xyrem for the treatment of narcolepsy. Specifically, Xyrem is prescribed to manage:
- Cataplexy — sudden loss of voluntary muscle control triggered by emotion
- Excessive daytime sleepiness (EDS) — the hallmark symptom of narcolepsy
Xyrem is distributed through an exclusive federal controlled-access program, can only be prescribed by authorized specialists (typically neurologists or sleep physicians), and is dispensed through a closed pharmacy network. Recreational GHB bears no legal or practical equivalence to prescribed Xyrem — possessing the pharmaceutical without a valid prescription is still a Schedule I criminal offence.
GHB Drug Overdose: What to Do in Canada
If you witness a suspected GHB overdose anywhere in Canada, act immediately:
- Call 911 — do not wait; GHB overdose can progress to fatal respiratory depression within minutes
- Place the unconscious person on their side (recovery position) to prevent aspiration of vomit
- Stay with them and monitor breathing continuously until paramedics arrive
- Tell paramedics what substance was taken — this is critical for correct treatment
- Know your rights under Canada’s Good Samaritan Drug Overdose Act — calling 911 provides legal protection from simple possession charges for everyone present
There is no antidote for GHB overdose — unlike opioids, which can be reversed with naloxone, GHB overdose can only be managed supportively through medical intervention. This makes calling for emergency help immediately the only effective response.
GHB Drug vs. Other Controlled Substances in Canada
GHB sits at the top of the Canadian drug penalty hierarchy and is uniquely dangerous among club drugs in having no pharmacological antidote — reinforcing why emergency medical response is the only intervention for overdose.
Getting Help for GHB Drug Use in Canada
Treatment and Support Resources
Whether you are struggling personally with GHB use, supporting a loved one, or a healthcare professional seeking clinical guidance, the following Canadian resources provide confidential, evidence-based help:
- CAMH — Centre for Addiction and Mental Health — Canada’s foremost addiction medicine institution; medically supervised detox and comprehensive rehabilitation
- Canadian Centre for Addictions — Private residential GHB treatment in Ontario (Port Hope, Cobourg, Ottawa)
- ConnexOntario — Free 24/7 Ontario-wide addiction and mental health referral line
- Here to Help BC — British Columbia harm reduction and treatment resources
- Health Canada Substance Use — Federal directory of licensed treatment centres nationwide
- Canadian Centre on Substance Use and Addiction (CCSA) — National research and policy body with comprehensive GHB resources
- Crisis Services Canada — Free, bilingual, 24/7 crisis and referral line